Novonesis A/S (CPH:NSIS.B)
430.50
-5.90 (-1.35%)
May 13, 2025, 11:18 AM CET
Novonesis Revenue
Novonesis had revenue of 1.08B EUR in the quarter ending March 31, 2025, with 26.26% growth. This brings the company's revenue in the last twelve months to 4.06B, up 53.93% year-over-year. In the year 2024, Novonesis had annual revenue of 3.83B with 59.58% growth.
Revenue (ttm)
4.06B EUR
Revenue Growth
+53.93%
P/S Ratio
6.72
Revenue / Employee
383.44K EUR
Employees
10,582
Market Cap
203.32B DKK
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.83B | 1.43B | 59.58% |
Dec 31, 2023 | 2.40B | 42.38M | 1.80% |
Dec 31, 2022 | 2.36B | 348.99M | 17.36% |
Dec 31, 2021 | 2.01B | 128.32M | 6.82% |
Dec 31, 2020 | 1.88B | -41.10M | -2.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SP Group | 2.92B |
H+H International | 2.75B |
Flügger group | 2.25B |
Scandinavian Investment Group | 30.30M |
RIAS A/S | 319.09M |
Hove A/S | 169.33M |
Novonesis News
- 1 day ago - Novonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Top 3 global stocks poised for 40% gains by 2025 - Invezz
- 6 months ago - Novonesis A/S (NVZMF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Novonesis: Underperformance In Price, But Now I'm Buying (Rating Upgrade) - Seeking Alpha
- 9 months ago - Novozymes A/S (NVZMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Invitation to an extraordinary shareholders' meeting of Novozymes A/S - GlobeNewsWire
- 1 year ago - The Novozymes Report 2023 - GlobeNewsWire